CAM L. GARNER

Profile

First Name

: CAM

Middle Name

: L.

Last Name

: GARNER

Related Companies
Titles
Company Name
Related People
DIRECTOR
ZOGENIX INC
JAMES C. BLAIR, LOUIS C. BOCK, STEPHEN J. FARR, CAM GARNER, KEN HAAS, J.D. HALDEMAN, ROGER L. HAWLEY, ERLE T. MAST, ARDA M. MINOCHERHOMJEE, ARDA M. MINOCHERHOMJEE, PH.D., DAVID W. NASSIF, ANN D. RHOADS, CYNTHIA Y. ROBINSON, KURT C. WHEELER, ALEX ZISSON
DIRECTOR
MERITAGE PHARMA INC
JAMES C. BLAIR, PH.D., MALCOLM R. HILL, ELAINE M. PHILLIPS, PH.D., ADAM K. SIMPSON, KENNETH J. WIDDER, M.D.
EXECUTIVE OFFICER, DIRECTOR
ELEVATION PHARMACEUTICALS INC
BRENTON K. AHRENS, WILLIAM M. GERHART, JAN LESCHLY, HEATH LUKATCH, HEATHER PRESTON, M.D., JAISIM SHAH, PRAVIN SONI, PH.D., AHMET TUTUNCU, M.D., PH.D.
DIRECTOR
NEURELIS, INC.
PRIYANKA BELAWAT, STEPHEN CARTT, CRAIG C. CHAMBLISS, CAM GARNER, DAVID A. GONYER, DAVID F. HALE, WILLIAM R. LARUE, KEVIN LI, HUAIZHENG PENG, GEORGE STUART, YONG ZHANG
DIRECTOR
EVOKE PHARMA INC
TODD BRADY, MATT D-ONOFRIO, SCOTT L. GLENN, DAVID A. GONYER, MALCOLM R. HILL, KENNETH J. WIDDER
DIRECTOR
KALYRA PHARMACEUTICALS, INC.
MICHAEL E. BREEDE, KEVIN D. BUNKER, CAM GALLAGHER, SCOTT L. GLENN, NED A. ISRAELSEN, DIRK A. THYE
EXECUTIVE OFFICER, DIRECTOR
ORPRO THERAPEUTICS, INC.
PETER B. HEIFETZ, PH.D., MARY JACQUELINE JOHNSON, JEFFREY W. RASER, JAMES WEIL
DIRECTOR
TOKALAS, INC.
JAMES B. BREITMEYER, M.D., PH.D., COOPER COLLINS, JAMES FREDDO, JAMES L. FREDDO, CAM GALLAGHER, CAM GARNER, SCOTT GLENN, SCOTT L. GLENN, DAVID F. HALE, DAVID JOHNSON, BRIAN LANNUTTI, WILLIAM R. LARUE, KAREN LUNDGREN, DANA MCGOWAN, LANGDON MILLER, LAUREN G. OTSUKI, CHARLES THEUER, M.D., RICHARD VINCENT
DIRECTOR
ALASTIN SKINCARE, INC.
TOM K. CHRISTENSON, SCOTT L. GLENN, DIANE S. GOOSTREE, WILLIAM R. LARUE, ANN D. RHOADS, MARK G. RUBIN, LYNN SALO, ELISABETH SANDOVAL, TED SCHWARZ, LYNN SOLO, MARYANNE K. SORGE
EXECUTIVE OFFICER, DIRECTOR
ZAVANTE THERAPEUTICS, INC.
EVELYN J. ELLIS-GROSSE, KEVIN FINNEY, CAM GALLAGHER, CAM GARNER, PATRICK HERON, DAVID HIRSCH, THEODORE R. SCHROEDER
DIRECTOR
ADIGICA HEALTH, INC.
STEPHEN CUSHMAN, BRANDON FISHMAN, DAVID F. HALE, TRACY JULIEN, ILYA NYKIN, HOWARD F. PALEFSKY, ROBERT ROSENBERG, KATHLEEN D. SCOTT, FREDERICK G. SLITER III, FREDERICK SLITER, III, WILLIAM F. STRAUSS
DIRECTOR
ONCTERNAL THERAPEUTICS, INC.
JAMES B. BREITMEYER, M.D., PH.D., COOPER COLLINS, JAMES FREDDO, JAMES L. FREDDO, CAM GALLAGHER, CAM GARNER, SCOTT GLENN, SCOTT L. GLENN, DAVID F. HALE, DAVID JOHNSON, BRIAN LANNUTTI, WILLIAM R. LARUE, KAREN LUNDGREN, DANA MCGOWAN, LANGDON MILLER, LAUREN G. OTSUKI, CHARLES THEUER, M.D., RICHARD VINCENT
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-03-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-17 
2020-10-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2020-10-19 
2019-05-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
2019-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
2018-08-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-08-07 
2018-03-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-09 
2017-09-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-12 
2017-06-29
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-30 
2017-03-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-27 
2016-12-09
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-27 
2016-10-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-27 
2016-10-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-30 
2016-08-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-29 
2016-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-24 
2016-03-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-27 
2016-03-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-30 
2016-02-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-11 
2015-08-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-30 
2015-08-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-07-27 
2015-04-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-06 
2014-03-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-19 
2013-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-11 
2013-11-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-14 
2013-08-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-14 
2011-12-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-16 
2011-11-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-18 
2011-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-09-19 
2011-01-27
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-18 
2010-07-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2010-07-01 
2010-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-16 
2010-02-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-01-19 
2010-01-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-13 
2009-12-15
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-10-05
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-09-22 
2009-08-27
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-08-17 
2009-07-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-07-17 
2009-06-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2009-06-15